Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00046384

Enrollment

Unknown

Registered

2002-10-01

Start date

2002-06-30

Completion date

2003-04-30

Last updated

2013-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar I Disorder

Brief summary

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Interventions

DRUGaripiprazole

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients with acute symptoms of Bipolar Disorder

Countries

Argentina, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026